Polycystic Ovary Syndrome: Evidence for Reduced Sensitivity of the Gonadotropin-Releasing Hormone Pulse Generator to Inhibition by Estradiol and Progesterone1
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Plasma LH is commonly elevated in women with the polycystic ovary syndrome (PCOS), but the underlying mechanisms are uncertain. We tested the hypothesis that the elevated LH in part reflects a reduced sensitivity of the hypothalamic GnRH pulse generator to suppression by estradiol (E2) and progesterone (P). In an initial protocol, normal controls (beginning on cycle days 8-10) and women with PCOS were given E2 transdermally and P by vaginal suppository (three times daily), to achieve plasma concentrations similar to those in the midluteal phase of an ovulatory cycle, for 21 days. Blood was obtained at 10-min intervals for 12 h before and on days 5, 10, 20, and 28 (7 days after E2 and P were discontinued). LH pulse amplitude and LH pulse frequency were suppressed in both PCOS and normal controls, but LH pulse frequency fell more rapidly in controls and was lower by day 10 (P < 0.05). Based on this time course a dose-response study was performed, in which E2 in constant dosage and varying concentrations of P were administered for 7 days. Pulsatile LH release was appraised on days 1 and 7. The frequency of LH pulse secretion was reduced in controls and was lower than that in patients with PCOS on day 7 (P < 0.0001). Plasma P concentrations of 13-15 ng/mL suppressed LH pulse frequency to a similar degree in PCOS and controls. In contrast, lower concentrations (P < 10 ng/mL) were more effective in suppressing GnRH/LH pulse frequency in controls (by > 45% of basal) than in PCOS (< 40%; P < 0.01). The data indicate that E2 and P can inhibit the activity of the hypothalamic GnRH pulse generator in women with PCOS. However, higher plasma concentrations of P were required to reduce GnRH/LH pulse frequency in PCOS compared to controls, suggesting an insensitivity of the GnRH pulse generator to suppression by E2 and P. These results suggest that an abnormality in the regulation of hypothalamic GnRH secretion is present in PCOS and may be a factor in the etiology of the disorder in adolescence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When developing female embryos are exposed to relatively high levels of testosterone—such as in females who develop PCOS—many aspects of HPG activity are affected. Hypothalamic sensitivity to steroid‐induced negative feedback is reduced, resulting in an increased frequency and amplitude of gonadotropin‐releasing hormone (GnRH) and luteinizing hormone (LH) pulses with corresponding increases in LH”
From Endometriosis and polycystic ovary syndrome are diametric disorders (2021) · cites this paper as Pastor et al., 1998
Citations
Cites
Amenorrhea associated with bilateral polycystic ovaries
Stein, I. F., & Leventhal, M. L. (1935) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30642-6 · Cited by 2,121
Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection
Veldhuis, J. D., & Johnson, M. L. (1986) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1986.250.4.e486 · Cited by 861 · cited 1×
“Data are presented as the mean 6 se. The number of LH pulses and pulse amplitude were measured by the computer algorithm Cluster ( 32 ), using parameters of threshold change corresponding to a t statistic of 2.45 for both the peak upstroke and the peak downstroke.”
MethodInfluentialNestler, J. E., & Jakubowicz, D. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350902 · Cited by 743
WILDT, L., HÄUSLER, A., MARSHALL, G., HUTCHISON, J. S., PLANT, T. M., BELCHETZ, P. E., & KNOBIL, E. (1981) · Endocrinology · doi:10.1210/endo-109-2-376 · Cited by 684
BARBIERI, R. L., MAKRIS, A., RANDALL, R. W., DANIELS, G., KISTNER, R. W., & RYAN, K. J. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-5-904 · Cited by 630 · cited 1×
“The fall in plasma LH after reduction of insulin in some studies may reflect the coexistent reduction in plasma androgen levels due to reduced enhancement of ovarian androgen secretion by insulin ( 53 , 54).”
BackgroundCharacterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
Rebar, R., Judd, H. L., Yen, S. S., Rakoff, J., Vandenberg, G., & Naftolin, F. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108400 · Cited by 622
Dunaif, A., Scott, D., Finegood, D., Quintana, B., & Whitcomb, R. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784087 · Cited by 524
EHRMAN, D. A., BARNES, R. B., & ROSENFIELD, R. L. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-322 · Cited by 502
Taylor, A. E., McCourt, B., Martin, K. A., Anderson, E. J., Adams, J. M., Schoenfeld, D., & Hall, J. E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4105 · Cited by 494
FILICORI, M., SANTORO, N., MERRIAM, G. R., & CROWLEY, W. F. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-6-1136 · Cited by 489
Cited by
Items 101–200 of 314
McGee, W. K., Bishop, C. V., Pohl, C. R., Chang, R. J., Marshall, J. C., Pau, F. K., Stouffer, R. L., & Cameron, J. L. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00310.2013 · Cited by 51
Self-citationvan Dam, E. W. C. M., Roelfsema, F., Veldhuis, J. D., Hogendoorn, S., Westenberg, J., Helmerhorst, F. M., Frölich, M., Krans, H. M. J., Meinders, A. E., & Pijl, H. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00377.2003 · Cited by 51
Velija-Ašimi, Z. (2013) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2013.2359 · Cited by 53
Veldhuis, J. D., Pincus, S. M., Garcia-Rudaz, M. C., Ropelato, M. G., Escobar, M. E., & Barontini, M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7125 · Cited by 48
Lucien, J. N., Ortega, M. T., & Shaw, N. D. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.09.009 · Cited by 51
“Other potential mediators include androgens, insulin sensitivity, and/or energy availability [4, 19, 20].”
BackgroundPolycystic ovarian syndrome: clinical and biological diagnosis
Bachelot, A. (2016) · Annales de biologie clinique · doi:10.1684/abc.2016.1184 · Cited by 58
Sexual dysfunction in polycystic ovary syndrome: a systematic review and meta-analysis
Loh, H. H., Yee, A. H. A., Loh, H. S., Kanagasundram, S., Francis, B., & Lim, L. (2020) · HORMONES · doi:10.1007/s42000-020-00210-0 · Cited by 54
“In addition, due to the androgen-induced insensitivity of hypothalamic gonadotrophin (GnRH) pulse generator to suppression by estrogen and progesterone [56], there is persistent and rapid GnRH pulsatility with preferential synthesis and release of LH over FSH, in which FSH is physiologically regulated by slow GnRH pul…”
BackgroundDumesic, D. A. (2003) · Biology of Reproduction · doi:10.1095/biolreprod.102.015164 · Cited by 47
“This reciprocity between reduced aromatase and elevated 5areductase activities emphasizes the inhibitory role of 5areduced androgens on aromatase, as demonstrated by the ability of 5a-androstane-3,17-dione, in amounts present in follicles of women with PCOS but not of normal women, to suppress E2 secretion by cultured…”
BackgroundEagleson, C. A., Bellows, A. B., Hu, K., Gingrich, M. B., & Marshall, J. C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030167 · Cited by 46
Self-citationRat BAT xenotransplantation recovers the fertility and metabolic health of PCOS mice
Du, L., Wang, Y., Li, C., Chen, L.-J., Cai, J.-Y., Xia, Z., Zeng, W., Wang, Z., Chen, X., Hu, F., et al. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0068 · Cited by 50
Activation of a Classic Hunger Circuit Slows Luteinizing Hormone Pulsatility
Coutinho, E. A., Prescott, M., Hessler, S., Marshall, C. J., Herbison, A. E., & Campbell, R. E. (2019) · Neuroendocrinology · doi:10.1159/000504225 · Cited by 50
McCartney, C. R. (2010) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2010.02029.x · Cited by 48
Polycystic ovarian syndrome: signs and feedback effects of hyperandrogenism and insulin resistance
Hernández-Jiménez, J. L., Barrera, D., Espinoza‐Simón, E., González, J., Ortiz-Hernández, R., Escobar, M. L., Echeverría, O. M., & Torres‐Ramírez, N. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.2003326 · Cited by 52
Ullah, R., Su, Y. R., Shen, Y., Li, C., Xu, X., Zhang, J., Huang, K., Rauf, N., He, Y., Cheng, J., et al. (2017) · Frontiers of Medicine · doi:10.1007/s11684-017-0530-y · Cited by 47
Targher, G. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1610000 · Cited by 40
Self-citationOvarian and extra-ovarian mediators in the development of polycystic ovary syndrome
Puttabyatappa, M., & Padmanabhan, V. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0079 · Cited by 43
Volk, K. M., Pogrebna, V. V., Roberts, J. A., Zachry, J. E., Blythe, S. N., & Toporikova, N. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00305 · Cited by 40
“However, several studies have found that elevated T is associated with increased basal LH secretion during the negative feedback phase of the estrous cycle [34, 104, 105].”
BackgroundLewandowski, K. C., Cajdler-Łuba, A., Salata, I., Bieńkiewicz, M., & Lewiñski, A. (2011) · PubMed · Cited by 51
Androgens and Insulin – Two Key Players in Polycystic Ovary Syndrome
Schüring, A. N., Schulte, N., Sonntag, B., & Kiesel, L. (2008) · Gyn�kologisch-geburtshilfliche Rundschau · doi:10.1159/000111465 · Cited by 53
Update on Animal Models of Polycystic Ovary Syndrome
Stener‐Victorin, E. (2022) · Endocrinology · doi:10.1210/endocr/bqac164 · Cited by 46
Abtahi‐Eivary, S., Moghimian, M., Soltani, M., Shoorei, H., Asghari, R., Hajizadeh, H., Shokoohi, M., Alami, S., & Ghaderi, F. K. (2017) · International Journal of Women s Health and Reproduction Sciences · doi:10.15296/ijwhr.2018.46 · Cited by 49
“However, some studies showed that a decrease in plasma levels of LH in response to the reduction of insulin may be similar to a phenomenon in which reduced plasma androgen is caused by a reduction in ovarian androgen secretion by insulin (38).”
BackgroundAbbott, D. H., Rogers, J., Dumesic, D. A., & Levine, J. E. (2019) · Medical Sciences · doi:10.3390/medsci7120107 · Cited by 46
“Neuroendocrine hypothalamic dysfunction, long identified with PCOS in women [136], includes diminished hypothalamic responsiveness to the actions of E2 and P4 [137,138].”
BackgroundPolycystic Ovary Syndrome and Hyperandrogenic States
Chang, R. J., & Dumesic, D. A. (2019) · Yen and Jaffe's Reproductive Endocrinology · doi:10.1016/b978-0-323-47912-7.00021-4 · Cited by 36
What causes anovulation in polycystic ovary syndrome?
Franks, S., & Hardy, K. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.03.001 · Cited by 40
Complementary Therapy in Polycystic Ovary Syndrome
Aquino, C. I., & Nori, S. L. (2014) · PubMed Central · doi:10.14273/unisa-247 · Cited by 45
Sanfilippo, J. S., & Lara‐Torre, E. (2009) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31819b6303 · Cited by 44
Kisspeptin and neurokinin B: roles in reproductive health
Koysombat, K., Tsoutsouki, J., Patel, A., Comninos, A. N., Dhillo, W. S., & Abbara, A. (2025) · Physiological Reviews · doi:10.1152/physrev.00015.2024 · Cited by 45
Silva, M. S. B., Decoster, L., Delpouve, G., Lhomme, T., Ternier, G., Prévot, V., & Giacobini, P. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104850 · Cited by 41
“For instance, elevated T levels impair progesterone-mediated restrain of the GnRH secretion 68,72 as PCOS patients are resistant to the suppres-sant effects of progesterone on GnRH/LH pulse frequency.”
BackgroundXu, G. Z., Zhao, X., Li, Z., Hu, J., Li, X., Li, J., & Chen, Y. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-022-01078-x · Cited by 37
Singh, R., Kaur, S., Yadav, S., & Bhatia, S. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.02.002 · Cited by 44
Moore, A. M. (2025) · Journal of Neuroendocrinology · doi:10.1111/jne.70028 · Cited by 39
“However, in PCOS patients, gonadal steroid hormone treatment fails to suppress GnRH/ LH pulse frequency to the same extent as controls 40 (Figure 1).”
Băculescu, N. (2013) · PubMed Central · Cited by 39
Experimental models of polycystic ovary syndrome: An update
Divyashree, S., Janhavi, P., Veeranna, R. P., & Peddha, M. S. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116911 · Cited by 39
The pathogenesis of polycystic ovary syndrome: Lessons from ovarian stimulation studies
Barnes, R. B. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03350782 · Cited by 37
Nonhuman Primates Contribute Unique Understanding to Anovulatory Infertility in Women
Abbott, D. H., Foong, S. C., Bernett, D. K., & Dumesic, D. A. (2004) · ILAR Journal · doi:10.1093/ilar.45.2.116 · Cited by 33
“The increased LH pulse frequency in PCOS women may result from the reduced ability of steroids to suppress the hypothalamic GnRH pulse generator, combined with increased LH responsiveness to GnRH from enhanced pituitary sensitivity to GnRH (Marshall and Eagleson 1999; Pastor et al. 1998; Rebar et al. 1976).”
BackgroundBrill, D. S., & Moenter, S. M. (2009) · Biology of Reproduction · doi:10.1095/biolreprod.109.079301 · Cited by 33
Moore, A. M. (2022) · Clinical Endocrinology · doi:10.1111/cen.14711 · Cited by 32
Ropelato, M. G., Rudaz, M. C. G., Escobar, M. E., Bengolea, S. V., Calcagno, M. L., Veldhuis, J. D., & Barontini, M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0402 · Cited by 37
Foecking, E. M., & Levine, J. E. (2005) · Gender Medicine · doi:10.1016/s1550-8579(05)80044-0 · Cited by 31
Veldhuis, J. D. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.8.3772 · Cited by 31
McCartney, C. R., Blank, S. K., & Marshall, J. C. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00371.2006 · Cited by 37
“, hyperandrogenemic states such as polycystic ovary syndrome (5, 25)].”
BackgroundSelf-citationCoyle, C. S., Prescott, M., Handelsman, D. J., Walters, K. A., & Campbell, R. E. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13110 · Cited by 33
Investigating the NPY/AgRP/GABA to GnRH Neuron Circuit in Prenatally Androgenized PCOS-Like Mice
Marshall, C. J., Prescott, M., & Campbell, R. E. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa129 · Cited by 29
“This elevated hypothalamic output is likely to stem in part from diminished negative feedback by ovarian steroid hormones, as exogenous estradiol and progesterone are less effective at reducing LH secretion in women with PCOS [7, 8].”
BackgroundMorphological evidence indicates a role for microglia in shaping the PCOS‐like brain
Sati, A., Prescott, M., Holland, S., Jasoni, C. L., Desroziers, E., & Campbell, R. E. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.12999 · Cited by 29
Silva, M. S. B., Decoster, L., Trova, S., Mimouni, N. E. H., Delli, V., Chachlaki, K., Yu, Q., Boehm, U., Prévot, V., & Giacobini, P. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2203503119 · Cited by 27
Marcondes, R. R., Carvalho, K. C., Duarte, D. C., Garcia, N., do Amaral, V. C., Simões, M. D. J., Turco, E. G. L., Soares, J. M., Baracat, E. C., & Maciel, G. A. R. (2015) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2015.01.006 · Cited by 29
“LH levels are elevated in 40–50% of patients with PCOS (Homburg, 2008), probably due to hypothalamic dysfunction (Pastor et al., 1998).”
BackgroundPuberty in the Female and Its Disorders
Rosenfield, R. L., Cooke, D. W., & Radovick, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00016-6 · Cited by 36
Diagnosis and Management of Polycystic Ovary Syndrome in Adolescent Girls
Lanzo, E. M., Monge, M. C., & Trent, M. (2015) · Pediatric Annals · doi:10.3928/00904481-20150910-10 · Cited by 31
Modelling aspects of oviduct fluid formation in vitro
Simintiras, C. A., Fröhlich, T., Sathyapalan, T., Arnold, G. J., Ulbrich, S. E., Leese, H. J., & Sturmey, R. G. (2016) · Reproduction · doi:10.1530/rep-15-0508 · Cited by 31
“…the effects of a physiologically relevant range of hormone concentrations on the in vitro model were similarly prepared to represent a minimum, mean and maximum pathophysiological endocrine profile (Kanchev et al. 1976, Pastor et al. 1998, Balen 2004, Di Sarra et al. 2013, O’Reilly et al. 2014).”
MethodMcCartney, C. R., Bellows, A. B., Gingrich, M. B., Hu, Y. F., Evans, W. S., Marshall, J. C., & Veldhuis, J. D. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00415.2003 · Cited by 30
Self-citationGibson, A. G., Jaime, J., Burger, L. L., & Moenter, S. M. (2021) · eNeuro · doi:10.1523/eneuro.0306-21.2021 · Cited by 26
“The elevated LH pulse frequency in patients with PCOS is attributable at least in part to reduced negative feedback actions of progesterone (Pastor et al., 1998).”
BackgroundUnfer, V., Casini, M. L., Marelli, G., Costabile, L., Gerli, S., & Renzo, G. C. D. (2005) · Gynecological Endocrinology · doi:10.1080/09513590500170049 · Cited by 24
“In another study of Pastor and collaborators [95], LH levels were normalized when progesterone vaginal suppository and transdermal estradiol were administered, reaching plasma progesterone concentrations of 13– 15 ng/ml.”
BackgroundGurule, S. C., Sustaita-Monroe, J. F., Padmanabhan, V., & Cardoso, R. C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1096187 · Cited by 28
Osteoporosis in polycystic ovary syndrome (PCOS) and involved mechanisms
Sudhakaran, G., Priya, P. S., Kannan, J., Haridevamuthu, B., Meenatchi, R., & Arockiaraj, J. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122280 · Cited by 25
Bitter Taste Receptor Ligand Improves Metabolic and Reproductive Functions in a Murine Model of PCOS
Wu, S., Xue, P., Grayson, N., Bland, J. S., & Wolfe, A. (2018) · Endocrinology · doi:10.1210/en.2018-00711 · Cited by 24
Gonadotropin dysfunction in women with polycystic ovary syndrome
Taylor, A. E. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.05.001 · Cited by 23
Obesity in Adolescent Girls: Is Excess Androgen the Real Bad Actor?
Marshall, J. C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2665 · Cited by 23
Self-citationPolycystic Ovary Syndrome and the Neuroendocrine Consequences of Androgen Excess
Silva, M. S. B., & Campbell, R. E. (2022) · Comprehensive physiology · doi:10.1002/cphy.c210025 · Cited by 27
Ovarian Androgens Maintain High GnRH Neuron Firing Rate in Adult Prenatally-Androgenized Female Mice
Dulka, E. A., Burger, L. L., & Moenter, S. M. (2019) · Endocrinology · doi:10.1210/endocr/bqz038 · Cited by 26
Nejad, E. S. T., Saedi, T., Saedi, S., Rashidi, B. H., Nekoo, Z. A., & Jahangiri, N. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.501872 · Cited by 22
Abbott, D. H., Vepraskas, S. H., Horton, T. H., Terasawa, E., & Levine, J. E. (2018) · Neuroendocrinology · doi:10.1159/000490570 · Cited by 20
Early onset adiposity: a pathway to polycystic ovary syndrome in adolescents?
Diamanti‐Kandarakis, E., Christakou, C. D., Kandaraki, E., & Alexandraki, K. (2007) · PubMed · Cited by 23
Investigating GABA Neuron–Specific Androgen Receptor Knockout in two Hyperandrogenic Models of PCOS
Sucquart, I. E., Coyle, C. S., Paris, V. R., Prescott, M., Glendining, K. A., Potapov, K., Begg, D. P., Gilchrist, R. B., Walters, K. A., & Campbell, R. E. (2024) · Endocrinology · doi:10.1210/endocr/bqae060 · Cited by 20
Moghetti, P., Carmina, E., Leo, V. D., Lanzone, A., Orio, F., Pasquali, R., & Toscano, V. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0274-y · Cited by 25
“Hyperinsulinemia might contribute to anovulation also reducing pituitary sensitivity to GnRH [19].”
BackgroundAnimal Models for the Study of Polycystic Ovarian Syndrome
Oakley, O. R., Lin, P.-C. P., Bridges, P. J., & Ko, C. J. (2011) · Endocrinology and Metabolism · doi:10.3803/enm.2011.26.3.193 · Cited by 21
To Study The Status of LH: FSH Ratio in Obese And Non-Obese Patients of Polycystic Ovarian Syndrome
Lal, L., Bharti, A., & Perween, A. (2017) · IOSR Journal of Dental and Medical Sciences · doi:10.9790/0853-1601012023 · Cited by 24
“Women with PCOS have abnormally rapid LH pulse with reduced response to progesterone feedback contributing to elevations in LH: FSH ratio [24].”
BackgroundBriden, L., Shirin, S., & Prior, J. C. (2020) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2020.11.008 · Cited by 23
Sun, B. Z., Kangarloo, T., Adams, J. M., Sluss, P. M., Chandler, D. W., Zava, D. T., McGrath, J. A., Umbach, D. M., & Shaw, N. D. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02400 · Cited by 21
Adrenarche and Polycystic Ovary Syndrome: A Tale of Two Hypotheses
Nader, S. (2007) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2007.05.001 · Cited by 25
Adult Female Acne: Recent Advances in Pathophysiology and Therapeutic Approaches
Amuzescu, A., Tampa, M. Ş., Matei, C., & Georgescu, S. R. (2024) · Cosmetics · doi:10.3390/cosmetics11030074 · Cited by 22
Adeyanju, O. A., Falodun, T. O., Fabunmi, O. A., Olatunji, L. A., & Soladoye, A. O. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.108742 · Cited by 18
PCOS and Inositols – Advances and Lessons We are Learning. A Narrative Review
Lentini, G., Querqui, A., Monti, N., & Bizzarri, M. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s524718 · Cited by 20
The influence of maternal androgen excess on the male reproductive axis
Holland, S., Prescott, M., Pankhurst, M. W., & Campbell, R. E. (2019) · Scientific Reports · doi:10.1038/s41598-019-55436-9 · Cited by 19
Palioura, E., Kandaraki, E., & Diamanti‐Kandarakis, E. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0003 · Cited by 19
“The loss of this physiological pattern and the decreased sensitivity of GnRH pulse generator to progesterone suppression in the presence of hyperandrogenemia, favor LH production over FSH and impairs follicular development [17].”
BackgroundAmato, G., Izzo, A., Tucker, A. T., & Bellastella, A. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00288-5 · Cited by 18
The Search for the Causes of Common Hyperandrogenism, 1965 to Circa 2015
Rosenfield, R. L. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae007 · Cited by 19
GnRH pulse generator activity in mouse models of polycystic ovary syndrome
Zhou, Z., Han, S. Y., Pardo-Navarro, M., Wall, E. G., Desai, R., Vas, S., Handelsman, D. J., & Herbison, A. E. (2025) · eLife · doi:10.7554/elife.97179.3 · Cited by 17
Desroziers, E. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13136 · Cited by 16
Sun, J., & Moenter, S. M. (2010) · Endocrinology · doi:10.1210/en.2010-0385 · Cited by 17
“Increased HVA calcium current in the presence of elevated androgens and absence of P, the typical steroid milieu of women with PCOS, may be associated with greater vesicle release per action potential; thus, these changes could increase output of this neuroendocrine system.”
InfluentialChronic anovulation and the polycystic ovary syndrome
KASE, N. G. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003254.012 · Cited by 16
Kim, S. H., Lundgren, J. A., Bhabhra, R., Collins, J. S. P., Patrie, J. T., Solorzano, C. M. B., Marshall, J. C., & McCartney, C. R. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02299 · Cited by 15
Self-citationIntertwined reproductive endocrinology: Puberty and polycystic ovary syndrome
Witchel, S. F., & Plant, T. M. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.07.004 · Cited by 16
“Women with PCOS required higher concentrations of estradiol and progesterone to suppress LH secretion [51].”
BackgroundHyperandrogenism during puberty in the development of polycystic ovary syndrome
Nader, S. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.03.013 · Cited by 17
Abedal-Majed, M. A., Springman, S. A., Jafar, H. D., Bell, B. E., Kurz, S. G., Wilson, K. E., & Cupp, A. S. (2022) · Journal of Animal Science · doi:10.1093/jas/skac151 · Cited by 15
Anatomy, Development, Histology, and Normal Function of the Ovary
Orsi, N. M., Baskind, N. E., & Cummings, M. (2014) · Springer eBooks · doi:10.1007/978-1-4471-2942-4_1 · Cited by 17
“On one hand, prolonged oligo-/anovulation results in affected women seldom experiencing regular postovulatory increases in progesterone which contributes to maintaining persistently rapid GnRH pulsatility, a phenomenon further aggravated by a reduced sensitivity of the GnRH pulse generator to progesterone negative fee…”
BackgroundLuteinizing hormone pulsatility in patients with major ovarian hyperandrogenism
Bachelot, A., Laborde, K., Bresson, J., Plu‐Bureau, G., Raynaud, A. C., BERTAGNA, X. Y., Mogenet, A., Mansour, M., Lucas-Jouy, V., Gayno, J. P., et al. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03347443 · Cited by 15
Abbud-Antaki, R., Ameduri, R. K., Rao, J. S., Nett, T. M., & Nilson, J. H. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.9.0348 · Cited by 19
“Our observations in mice have been recently confirmed in women with polycystic ovary syndrome who appear to have elevated levels of LH as a result of resistance to steroid-negative feedback (40).”
BackgroundPremature progesterone rise as a trigger of polycystic ovarian syndrome
Dozortsev, D. I., Pellicer, A., & Diamond, M. P. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.07.007 · Cited by 14
The impact of obesity on hyperandrogenemia in Korean girls
Kang, M. J., Yang, S., & Hwang, I. T. (2016) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2016.21.4.219 · Cited by 13
An endocrinological perspective on polycystic ovarian syndrome
Basak, S., Dixit, A. K., Dey, R. K., Puia, L., Bora, M., Yr, S. K., & Babu, G. (2025) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2025.112524 · Cited by 13
Hutchens, E. G., Ramsey, K. A., Howard, L. C., Abshire, M. Y., Patrie, J. T., & McCartney, C. R. (2016) · Physiological Reports · doi:10.14814/phy2.12891 · Cited by 14
Vastagh, C., Rodolosse, A., Solymosi, N., Farkas, I., Auer, H., Sárvári, M., & Liposits, Z. (2015) · Neuroendocrinology · doi:10.1159/000430818 · Cited by 15
Role of GnRH drive in the pathophysiology of polycystic ovary syndrome
Leondires, M. P., & Berga, S. L. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03347331 · Cited by 14
Polycystic Ovary Syndrome: Implications for the Advanced Practice Nurse in Primary Care
Markle, M. E. (2001) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2001.tb00240.x · Cited by 11
Lundgren, J. A., Kim, S. H., Solorzano, C. M. B., McCartney, C. R., & Marshall, J. C. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02068 · Cited by 12
Self-citationMarshall, J. C., Eagleson, C. A., & McCartney, C. R. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00031-x · Cited by 11
Self-citationAnatomy, Development, Histology and Normal Function of the Ovary
Orsi, N. M., Baskind, N. E., & Cummings, M. (2023) · Essentials of Diagnostic Gynecological Pathology. · doi:10.1007/978-3-031-39659-5_1 · Cited by 14
Mahalingaiah, S., Winter, M. R., & Aschengrau, A. (2016) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.07.005 · Cited by 11
“Though no studies have been conducted to test this hypothesis, neuroendocrine toxicity resulting in reduced functionality from reduced synapses and gap junctions thereby affecting pulsatility and surge functions of the GnRH neurons may promote development of disorders of ovulation, such as polycystic ovary syndrome an…”
BackgroundNeuroendocrinology of Reproduction
McCartney, C. R., & Marshall, J. C. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00001-9 · Cited by 10
Self-citationUlloa‐Aguirre, A., Portocarrero-Ortiz, L. A., Zariñán, T., Olivares, A., Carranza‐Lira, S., Veldhuis, J. D., & López-Alvarenga, J. C. (2006) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61079-6 · Cited by 10
Metadata
- Authors
- Pastor, C. L., Griffin-Korf, M. L., Aloi, J. A., Evans, W. S., & Marshall, J. C.
- Affiliations
- University of Virginia (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1998-02
- Volume
- 83
- Issue
- 2
- Pages
- 582-590
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2122612739
- Cited by
- 263
- References
- 54
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 10 · 2023: 8 · 2022: 15 · 2021: 12 · 2020: 14 · 2019: 20 · 2018: 9 · 2017: 10 · 2016: 8 · 2015: 12 · 2014: 11 · 2013: 12 · 2012: 6
- FWCI
- 7.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hd016000-18)
- National Center for Research Resources (M01RR000847, M01-RR 00847)
- NIH Clinical Center
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30 HD28934, R01-HD-16000, P30HD028934)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- polycystic ovary syndrome, gonadotropin-releasing hormone, LH pulse frequency, LH pulse amplitude, estradiol, progesterone, hypothalamic-pituitary-gonadal axis, LH secretion regulation, transdermal estradiol, vaginal progesterone
- MeSH terms
- Adult, Dose-Response Relationship, Drug, Estradiol, Female, Follicle Stimulating Hormone, Humans, Hypothalamus, Kinetics, Luteinizing Hormone, Gonadotropin-Releasing Hormone, Periodicity, Polycystic Ovary Syndrome, Progesterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.